| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/00952990.2017.1306747 |
| P698 | PubMed publication ID | 28387530 |
| P50 | author | Marc Galanter | Q6755566 |
| P2860 | cites work | Alcoholics Anonymous and other 12-step programmes for alcohol dependence | Q24245119 |
| Participation in treatment and Alcoholics Anonymous: a 16-year follow-up of initially untreated individuals | Q24642818 | ||
| Evidence based medicine: what it is and what it isn't | Q24655756 | ||
| Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes | Q28082657 | ||
| Mortality and morbidity attributable to use of addictive substances in the United States | Q28142616 | ||
| Addiction as a Public Health Problem | Q52265505 | ||
| Assessment of spirituality and its relevance to addiction treatment. | Q52291349 | ||
| The Minnesota Model in the Management of Drug and Alcohol Dependency: miracle, method or myth? Part I. The Philosophy and the Programme | Q30404780 | ||
| Drug treatment and 12-step program participation: the additive effects of integrated recovery activities | Q33886608 | ||
| Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study | Q33948112 | ||
| Orientation toward spirituality and self-help approaches in the therapeutic community | Q34312568 | ||
| The National Comorbidity Survey Replication (NCS-R): background and aims. | Q34339246 | ||
| Estimating the efficacy of Alcoholics Anonymous without self-selection bias: an instrumental variables re-analysis of randomized clinical trials | Q34449320 | ||
| Long-term recovery in alcoholics | Q34514472 | ||
| Alcoholics anonymous effectiveness: faith meets science | Q34973679 | ||
| Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure | Q35042742 | ||
| Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: a multiple mediator analysis | Q35624108 | ||
| The effects of continuing care on emerging adult outcomes following residential addiction treatment | Q35876145 | ||
| Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations | Q35937004 | ||
| Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes | Q36030715 | ||
| Consistency between beliefs and behavior regarding use of substances in recovery | Q36051450 | ||
| Youth recovery contexts: the incremental effects of 12-step attendance and involvement on adolescent outpatient outcomes. | Q36089606 | ||
| The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking | Q36655825 | ||
| Do Drug-Dependent Patients Attending Alcoholics Anonymous Rather than Narcotics Anonymous Do As Well? A Prospective, Lagged, Matching Analysis | Q36848042 | ||
| Narrative review: buprenorphine for opioid-dependent patients in office practice | Q36959052 | ||
| Effectiveness of Making Alcoholics Anonymous Easier: a group format 12-step facilitation approach | Q37352298 | ||
| Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients | Q38135704 | ||
| Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. | Q38421990 | ||
| A 3-year study of addiction mutual-help group participation following intensive outpatient treatment | Q40299391 | ||
| Hazelden's model of treatment and its outcome | Q40840299 | ||
| Spiritual recovery movements and contemporary medical care | Q40880723 | ||
| Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes | Q43694294 | ||
| Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment | Q44334201 | ||
| Medication-assisted treatment for opioid dependence in Twelve Step-oriented residential rehabilitation settings | Q44337025 | ||
| Confronting the stigma of opioid use disorder--and its treatment | Q44343587 | ||
| Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial | Q44350474 | ||
| Spirituality-based recovery from drug addiction in the twelve-step fellowship of narcotics anonymous | Q44557500 | ||
| Reduced substance-abuse-related health care costs among voluntary participants in Alcoholics Anonymous | Q46333581 | ||
| What is recovery? A working definition from the Betty Ford Institute | Q46986562 | ||
| Mental Health and Substance-Use Reforms--Milestones Reached, Challenges Ahead | Q47958530 | ||
| Outcomes monitoring in Minnesota: treatment implications, practical limitations | Q50118353 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2017-04-07 | |
| P1433 | published in | American Journal of Drug and Alcohol Abuse | Q15755465 |
| P1476 | title | Combining medically assisted treatment and Twelve-Step programming: a perspective and review |
| Q90746602 | Canadian Guidelines on Opioid Use Disorder Among Older Adults |
| Q92669629 | Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence |
| Q92991156 | MECHANISMS OF BEHAVIOR CHANGE IN 12-STEP APPROACHES TO RECOVERY IN YOUNG ADULTS |
| Q58735248 | Overeaters Anonymous: A Mutual-Help Fellowship for Food Addiction Recovery |
| Q92349434 | Spiritual experiences are related to engagement of a ventral frontotemporal functional brain network: Implications for prevention and treatment of behavioral and substance addictions |
| Q41997097 | The mixed message behind "Medication-Assisted Treatment" for substance use disorder |
Search more.